Application
Western blot analysis of PCDH17 Antibody (C-term) in 293 cell line lysates (35ug/lane). PCDH17 (arrow) was detected using the purified Pab.Application
PCDH17 Antibody (C-term) flow cytometric analysis of 293 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | PCDH17 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | PCDH17; PCDH68; PCH68; Protocadherin-17; Protocadherin-68 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | PCDH68 PCH68 |
|---|---|
| Alternative Names | PCDH17 PCDH68 PCH68 Protocadherin-17 Protocadherin-68 |
| Molecular Weight(MW) | 126229 Da |
| Function | Potential calcium-dependent cell-adhesion protein. |
| Tissue Specificity | This PCDH17 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1114~1144 amino acids from the C-terminal region of human PCDH17. |
| Cellular Localization | Cell membrane; Single-pass type I membrane protein (By similarity) |
| Entrez Gene | 27253 |
|---|
Application
Western blot analysis of PCDH17 Antibody (C-term) in 293 cell line lysates (35ug/lane). PCDH17 (arrow) was detected using the purified Pab.
Application
PCDH17 Antibody (C-term) flow cytometric analysis of 293 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
